MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MediciNova Inc (MNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10045
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and respiratory diseases. The company’s non-core programs formulations developed for indications that include treatment of bronchial asthma; interstitial cystitis; solid tumors; and for the treatment of preterm labor. It has partnerships with various companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd and Meiji Seika Kaisha Ltd., to develop and commercialize its products. MediciNova is headquartered in California, the US.

MediciNova Inc (MNOV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediciNova Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediciNova Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MediciNova Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MediciNova Enters into Agreement with University of Sydney 10
MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 11
Licensing Agreements 12
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 12
Equity Offering 13
MediciNova Raises USD40 Million in Public Offering of Shares 13
MediciNova to Raise up to USD30 Million in Public Offering of Shares 15
MediciNova Raises USD17.5 Million in Public Offering of Shares 16
MediciNova Completes First Tranche Of Public Offering Of Common Stock For US$2.8 Million 17
MediciNova Completes First Tranche Of Private Placement Of Common Stock For US$1 Million 18
MediciNova Inc – Key Competitors 19
MediciNova Inc – Key Employees 20
MediciNova Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Nov 09, 2017: MediciNova Appoints Hideki Nagao to its Board of Directors 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
MediciNova Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediciNova Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediciNova Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MediciNova Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MediciNova Enters into Agreement with University of Sydney 10
MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 11
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 12
MediciNova Raises USD40 Million in Public Offering of Shares 13
MediciNova to Raise up to USD30 Million in Public Offering of Shares 15
MediciNova Raises USD17.5 Million in Public Offering of Shares 16
MediciNova Completes First Tranche Of Public Offering Of Common Stock For US$2.8 Million 17
MediciNova Completes First Tranche Of Private Placement Of Common Stock For US$1 Million 18
MediciNova Inc, Key Competitors 19
MediciNova Inc, Key Employees 20
MediciNova Inc, Subsidiaries 21

List of Figures
MediciNova Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediciNova Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Triumph Group Inc:企業のM&A・事業提携・投資動向
    Triumph Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Electrabel SA-エネルギー分野:企業M&A・提携分析
    Summary Electrabel S.A. (Electrabel) is an energy utility company. It produces and sells electricity; supplies natural gas; and provides related energy products and services. The company operates diversified electricity generating facilities such as thermal, nuclear and renewable power plants, inclu …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Siemens AG:企業の戦略・SWOT・財務情報
    Siemens AG - Strategy, SWOT and Corporate Finance Report Summary Siemens AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Allergy Therapeutics Plc (AGY)-製薬・医療分野:企業M&A・提携分析
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • Histogen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies based on the products of cells grown under simulated embryonic conditions. The company’s products include a soluble multipotent cell conditioned media and insoluble extracellular matrix. Its products are …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Bilfinger SE (GBF):電力:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務分析
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • R-Pharm:製薬・医療:M&Aディール及び事業提携情報
    Summary R-Pharm is a pharmaceutical company that manufactures and markets therapeutic drugs. The company offers drugs in areas of oncology, hematology, cardiology, immunology, and antibacterial and anti-viral diseases. It offers solutions on treatment of HIV-infection, organ transplantation, dissemi …
  • Mitsui O.S.K. Lines, Ltd.:企業の戦略・SWOT・財務情報
    Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Medison Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Medison Pharma Ltd (Medison) is a drug company that develops and manufactures medical products. The company's oncology products include vectibix, myocet, aranesp, symphony and coloprint. Its neurology products are avonex, tysabri, fampyra, provigil, stryker, dysport and firdapse. Medison off …
  • PTT Public Co Ltd (PTT):電力:M&Aディール及び事業提携情報
    Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, …
  • VIDA Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary VIDA Diagnostics Inc (VIDA) is a medical technology company that provides clinical imaging software and analysis services for early detection, evaluation, and treatment of pulmonary diseases. The company offers VIDA exchange and VIDA vision. Its products are used in airway mapping, lung volu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆